(Q38966843)

8 September 2017

title

YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression (English)

1 reference

Erratum: YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression

8 September 2017

1 reference

corrigendum / erratum

0 references

author name string

Yijun Gao

1

1 reference

8 September 2017

Wenjing Zhang

2

1 reference

8 September 2017

Xiangkun Han

3

1 reference

8 September 2017

Fuming Li

4

1 reference

8 September 2017

Xujun Wang

5

1 reference

8 September 2017

Rui Wang

6

1 reference

8 September 2017

Zhaoyuan Fang

7

1 reference

8 September 2017

Xinyuan Tong

8

1 reference

8 September 2017

Shun Yao

9

1 reference

8 September 2017

Fei Li

10

1 reference

8 September 2017

Yan Feng

11

1 reference

8 September 2017

Yihua Sun

12

1 reference

8 September 2017

Yingyong Hou

13

1 reference

8 September 2017

Zhongzhou Yang

14

1 reference

8 September 2017

Kunliang Guan

15

1 reference

8 September 2017

Haiquan Chen

16

1 reference

8 September 2017

Lei Zhang

17

1 reference

8 September 2017

Hongbin Ji

18

1 reference

8 September 2017

language of work or name

English

0 references

publication date

13 August 2014

1 reference

8 September 2017

published in

Nature Communications

1 reference

8 September 2017

volume

5

1 reference

8 September 2017

page(s)

4629

1 reference

https://scigraph.springernature.com/pub.10.1038/ncomms5629

8 September 2017

exact match

0 references

cites work

From cell structure to transcription: Hippo forges a new path

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

The bantam microRNA is a target of the hippo tumor-suppressor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

The Hippo-YAP pathway: new connections between regulation of organ size and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Stem cell regulation by the Hippo pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Yap1 acts downstream of α-catenin to control epidermal proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

The Hippo pathway and human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Expression of Yes-associated protein in common solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Elucidation of a universal size-control mechanism in Drosophila and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Cell of origin of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Mouse models for human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

LKB1 modulates lung cancer differentiation and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Prognostic significance of TAZ expression in resected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

TAZ is a novel oncogene in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Role of YAP/TAZ in mechanotransduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Cells of origin in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Tracing the cellular origin of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Glioblastoma stem-like cells give rise to tumour endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Clonal analysis of adenosquamous carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

p63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

p63: Molecular complexity in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Restriction of intestinal stem cell expansion and the regenerative response by YAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Yes-associated protein (YAP) functions as a tumor suppressor in breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Rapid increase of serum neuron specific enolase level and tachyphylaxis of EGFR-tyrosine kinase inhibitor indicate small cell lung cancer transformation from EGFR positive lung adenocarcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

inferred from DOI database lookup

7 January 2021

based on heuristic

Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

inferred from DOI database lookup

7 January 2021

based on heuristic

Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5629

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCOMMS5629

1 reference

Dimensions Publication ID

8 September 2017

0 references

1030309425

0 references

1 reference